Health News Releases

December 19, 2023 13:50

DENTALIS Animal Health Awarded with VOHC Seal

Dentalis Animal Health, dedicated to the development of superior oral health care products for companion animals, proudly announces its first Veterinary Oral Health Council (VOHC) approval. Dentalis'

December 19, 2023 10:45

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery and development of novel antibody therapeutics, today announces an antibo

December 19, 2023 09:40

Lydia AI Expands Reach in Korea Through Strategic Partnerships with Hecto Data and Tobecon

Lydia AI, a leading Canadian health AI company, is thrilled to announce its strategic collaborations with Hecto Data and Tobecon Inc., two prominent technology companies in South Korea. These partners

December 17, 2023 10:50

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53870362&newsitemid=20231213527272&lan=en-US&anchor=TSE%3A4502%2FNYSE%

December 15, 2023 15:20

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is reinforcing its focus on q

December 15, 2023 14:50

Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=53870688&newsitemid=20231214617151&lan=en-US&anchor=Parse+Biosciences&index=1&md

December 15, 2023 10:40

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have signed an agreement for the mutual supply of reagent raw materi

December 14, 2023 13:20

WHOOP Announces Its “Year In Review” Celebrating That 2023 Was the Year Human Performance Became a Lifestyle

WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F&esheet=53869622&newsitemid=20231211786571&lan=en-US&anchor=WHOOP&index=1&md5=fa89e2d87172001de9758c69dd9680af)

December 14, 2023 12:10

AOP Health Receives Market Authorization for Landiolol in Canada

At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada)

December 13, 2023 11:10

Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production

Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today the peer-reviewed publication of, “A novel role for the adenovirus L4 region 22K and 33K proteins in adeno-associa

December 12, 2023 16:30

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=53868764&newsitemid=20231210873994&lan=en-US&anchor=Masimo&index=1&md5=6909e6cf722103d0ab237709071a118c)(

December 12, 2023 14:09

BIO KOREA 2024: Registration Now Open for Programs and Booths

BIO KOREA 2024 (https://www.biokorea.org/index.asp?pLn=Eng), jointly hosted by the Korea Health Industry Development Institute (KHIDI, President: Cha Soon-do) and Chungcheongbuk-do (Governor: Kim Youn

December 11, 2023 16:00

Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement

Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are today announcing a research and development collaboration to drive forward new microbiome-based biotherapeutics

December 08, 2023 16:10

World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research

Mary Kay Inc. (https://marykayglobal.com/), the world's No. 1 direct selling skin care and color cosmetics brand[1] and its company-sponsored foundations, including the Mary Kay Ash Foundation (https:

December 08, 2023 14:15

Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting

AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treat

December 07, 2023 14:30

ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perre

December 07, 2023 11:20

PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase I/II Clinical Trial

PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces completion of enrolment of the fourth cohort of pati

December 06, 2023 13:45

Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis

Merck, a leading science and technology company, today announced that its two Phase III EVOLUTION clinical trials (evolutionRMS 1 and evolutionRMS 2) investigating the efficacy and safety of evobrutin

December 06, 2023 10:45

Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in

December 05, 2023 10:35

QPS Holdings, LLC Expands Operations in Springfield, Missouri

QPS Holdings, LLC, a global contract research organization has expanded operations in Springfield, Missouri. The new facilities include a clinical (safety) laboratory, an updated self-contained pharma

December 05, 2023 10:25

IFRC-DREF calls on global donors to help the world ‘Stand Tall’ in the face of accelerating humanitarian need - supporting smarter and faster disaster relief

The International Federation of Red Cross and Red Crescent Societies (IFRC (https://www.ifrc.org/)) has launched a new campaign to address rapidly escalating climate driven humanitarian crises. It cal

December 05, 2023 10:10

Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib

Merck, a leading science and technology company, today announced a license agreement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated

December 05, 2023 09:50

AIT Worldwide Logistics acquires European life sciences specialist Mach II Shipping Ltd

AIT Worldwide Logistics, a global supply chain solutions leader, has acquired Mach II Shipping Ltd, a U.K.-based freight forwarder specializing in worldwide distribution of pharmaceuticals and related

December 04, 2023 15:30

Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28

Global donors at the 2023 Reaching the Last Mile Forum today pledged a collective US$777.2 million to help control, eliminate, and eradicate neglected tropical diseases (NTDs), in a landmark push to a

December 04, 2023 14:15

Beyond Medtech: Healthcare+ Expo Taiwan Sets New Stage for Global Innovation in Future AI Healthcare

The Healthcare+ Expo Taiwan, currently taking place at Nangang Exhibition Hall 1 from November 30 to December 3, 2023, is poised to redefine the landscape of AI healthcare on a global scale. This year

News by Region

News by Industry